Author

Henrik Biverstål

Karolinska InstitutetORCID 0000-0002-2097-7658Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

Axel AbeleiniD· 1 shared Azad FarzadfardiD· 1 shared Daniel E. OtzeniD· 1 shared Hannah KluteiD· 1 shared Jan JohanssoniD· 1 shared Jan Stanislaw NowakiD· 1 shared Janni Nielsen· 1 shared Laurène AdamiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

Axel AbeleinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiophysicsProtein SciencePeer-reviewedJul 9, 2024

Specific inhibition of α-synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS

Laurène Adam, Rakesh Kumar, Luis Enrique Arroyo‐García…·Axel Abelein

This study shows that the Bri2 BRICHOS domain inhibits α-synuclein oligomer formation and toxicity by suppressing secondary nucleation and binding oligomers, suggesting its potential as a therapeutic target for Parkinson's disease.

12 citations

humanproteomics

𝕏 PostBluesky